FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

30764911000001102: Vitamin B compound tablets (Almus Pharmaceuticals Ltd) 28 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 14-Oct 2015. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
94171801000001117 Vitamin B compound tablets (Almus Pharmaceuticals Ltd) 28 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
94171901000001111 Vitamin B compound tablets (Almus Pharmaceuticals Ltd) 28 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Vitamin B compound tablets (Almus Pharmaceuticals Ltd) 28 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Vitamin B compound tablets (Almus Pharmaceuticals Ltd) 28 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Vitamin B compound tablets (Almus Pharmaceuticals Ltd) 28 tablet Is a Vitamin B compound tablets 28 tablet true Inferred relationship Existential restriction modifier
Vitamin B compound tablets (Almus Pharmaceuticals Ltd) 28 tablet Has AMP Vitamin B compound tablets (Almus Pharmaceuticals Ltd) true Inferred relationship Existential restriction modifier
Vitamin B compound tablets (Almus Pharmaceuticals Ltd) 28 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Vitamin B compound tablets (Almus Pharmaceuticals Ltd) 28 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Vitamin B compound tablets (Almus Pharmaceuticals Ltd) 28 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Vitamin B compound tablets (Almus Pharmaceuticals Ltd) 28 tablet Has specific active ingredient Nicotinamide false Inferred relationship Existential restriction modifier
Vitamin B compound tablets (Almus Pharmaceuticals Ltd) 28 tablet Has specific active ingredient Riboflavin false Inferred relationship Existential restriction modifier
Vitamin B compound tablets (Almus Pharmaceuticals Ltd) 28 tablet Has specific active ingredient Thiamine hydrochloride false Inferred relationship Existential restriction modifier
Vitamin B compound tablets (Almus Pharmaceuticals Ltd) 28 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Vitamin B compound tablets (Almus Pharmaceuticals Ltd) 28 tablet Legal category General sales list true Inferred relationship Existential restriction modifier
Vitamin B compound tablets (Almus Pharmaceuticals Ltd) 28 tablet Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Vitamin B compound tablets (Almus Pharmaceuticals Ltd) 28 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Vitamin B compound tablets (Almus Pharmaceuticals Ltd) 28 tablet Has specific active ingredient Thiamine hydrochloride true Inferred relationship Existential restriction modifier
Vitamin B compound tablets (Almus Pharmaceuticals Ltd) 28 tablet Has specific active ingredient Nicotinamide true Inferred relationship Existential restriction modifier
Vitamin B compound tablets (Almus Pharmaceuticals Ltd) 28 tablet Has specific active ingredient Riboflavin true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start